Table 6.
Samples | Univariate | Multivariate | |||
---|---|---|---|---|---|
HR (95% CI) | p-Value | HR (95% CI) | p-Value | ||
Men and women (n = 1025) |
CC | 0.62 (0.42–0.93) | 0.0202 | 0.64 (0.41–1.01) | 0.0530 |
CA | 0.92 (0.69–1.22) | 0.5579 | 0.86 (0.63–1.18) | 0.3550 | |
Men and women, stages I, II, III (n = 807) |
CC | 0.59 (0.38–0.89) | 0.0145 | 0.62 (0.39–0.99) | 0.0446 |
CA | 0.84 (0.63–1.14) | 0.2616 | 0.85 (0.62–1.18) | 0.3331 | |
Men (n = 485) | CC | 0.49 (0.27–0.89) | 0.0183 | 0.48 (0.25–0.94) | 0.0320 |
CA | 0.99 (0.68–1.44) | 0.9545 | 0.85 (0.55–1.30) | 0.4450 | |
Men, stages I, II, III (n = 387) |
CC | 0.43 (0.23–0.82) | 0.0099 | 0.44 (0.21–0.89) | 0.0219 |
CA | 0.93 (0.63–1.38) | 0.7278 | 0.86 (0.56–1.32) | 0.4870 | |
Men, 5 years follow-up (n = 304) |
CC | 0.46 (0.24–0.89) | 0.0200 | 0.4 (0.20–0.83) | 0.0139 |
CA | 0.95 (0.63–1.42) | 0.7940 | 0.68 (0.42–1.11) | 0.1218 | |
Men, 5 years follow-up, stages I, II, III (n = 254) |
CC | 0.4 (0.19–0.83) | 0.0136 | 0.36 (0.16–0.79) | 0.0107 |
CA | 0.9 (0.59–1.37) | 0.6191 | 0.7 (0.43–1.13) | 0.1461 |